Skip to main content

Calidi Biotherapeutics, Inc 8-K, filed Sep 16, 2022

Calidi Biotherapeutics, Inc. (CLDI)

8-K 2022-09-16 For: 2022-09-13
View Original
Added on April 12, 2026

About this 8-K

Calidi Biotherapeutics, Inc filed this 8-K on September 16, 2022, reporting on events of September 13, 2022.

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 2.03: New debt or off-balance-sheet obligation
  • Item 5.02: Director or officer change, or executive pay
  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 5.07: Shareholder vote results
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits